Source:http://linkedlifedata.com/resource/pubmed/id/15827015
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2005-4-13
|
pubmed:abstractText |
The potassium channel blocker 4-aminopyridine (4-AP) restored vertical smooth pursuit and gaze holding in light in one patient with upbeat (UBN) and in one with downbeat nystagmus (DBN). Without a visible target, however, 4-AP had no effect on UBN, but DBN vanished. We hypothesize that this difference in the effects of 4-AP, which is known to increase the excitability of cerebellar Purkinje cells, can be attributed to the different lesion sites involved in UBN and DBN.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0077-8923
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
1039
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
528-31
|
pubmed:meshHeading |
pubmed-meshheading:15827015-4-Aminopyridine,
pubmed-meshheading:15827015-Adult,
pubmed-meshheading:15827015-Aged,
pubmed-meshheading:15827015-Eye Movements,
pubmed-meshheading:15827015-Humans,
pubmed-meshheading:15827015-Male,
pubmed-meshheading:15827015-Mesencephalon,
pubmed-meshheading:15827015-Nystagmus, Physiologic,
pubmed-meshheading:15827015-Potassium Channel Blockers,
pubmed-meshheading:15827015-Vision Disorders
|
pubmed:year |
2005
|
pubmed:articleTitle |
Effect of 4-aminopyridine on upbeat and downbeat nystagmus elucidates the mechanism of downbeat nystagmus.
|
pubmed:affiliation |
Center for Sensorimotor Research, Department of Neurology, Ludwig-Maximilian-University, Munich, Germany. sglasauer@nefo.med.uni-muenchen.de
|
pubmed:publicationType |
Journal Article,
Case Reports
|